The Global Micro Bioreactor Market is expected to grow at a high CAGR of 7.3% during the forecasting period (2022-2029).
Microbioreactor’s serve as a multitude of scale-down needs for bioprocesses based on mammalian cells. Microbioreactor technology has allowed for rapid advancements in biotechnology, development, and investigation of various biological systems from industrial biotechnology and pharmaceutical biotechnology. Micro bioreactors range in complexity from simple micro-tier-based systems to complex automated parallel bioreactors designed to effective scaling up/down of conventional pilot and large-scale bioprocess. Currently, most micro bioreactors are designed for batch and fed-batch processing, many companies are focusing on developing micro bioreactors with continuous chemostat mode operation.
Increasing demand for miniature bioreactors for research and development of novel technologies for personalized medicine drives the micro bioreactor market globally during the forecast period. Increasing demand for personalized medicines coupled with a significant rise in micro bioreactors' utilization to produce necessary therapies drives the global micro bioreactor market during the forecast period. The majority of drugs under the pipeline stage by globally dominating companies are related to personalized medicine and biomarkers. It is estimated that 30-40% of the novel drugs in the pipeline are being developed in conjunction with a biomarker making this relevant to treating diseases. Additionally, the increased demand for patient-specific therapies and cell culture contributes to the microbioreactor market's growth during the forecast period.
However, the availability of alternatives at lower prices and minimal availability in low-economy nations are major factors hindering the growth of the Micro Bioreactor market globally during the forecast period.
The global micro bioreactor market is segmented into Biopharmaceutical Industry, Food & Food Additives, Educational Institutions, and others.
The educational and training institutions extensively use Micro-Bioreactors to impart technical knowledge to the students or professionals through live exposure. The majority of educational institutions in the medical, pharmaceutical, food, and chemical domains are increasing, focusing on developing novel technologies to meet industry requirements for sustainable technologies. The significant rise in educational institutions' investments towards research activities in targeted medicines, or regenerative medicines and cell culture medium, boosts huge market demand for micro bioreactors from educational institutions globally during the forecast period.
By region, the global Micro Bioreactor market is segmented into North America, South America, Europe, Asia-Pacific, Middle-East, and Africa.
Europe is the second most dominant region, followed by North America in the global micro bioreactor market due to pharmaceutical companies' wide presence and a significant rise in micro bioreactors' utilization to produce novel ingredients and drugs for specific/uncured diseases. UK, Germany, and many other countries in Europe are occupying significant market share in the European micro bioreactor market due to the high presence of research & development laboratories across the globe coupled with a significant rise in investments by the respective companies to boost the development of novel drugs through micro bioreactors. According to the study published in the European Federation of Pharmaceutical Industries and Associations, the R&D expenditure by the pharmaceutical companies located across the European Union increased from USD 38.362 billion in 2017 to USD 41.536 billion in 2018.
The global micro bioreactor market is highly consolidated with very companies operating in the market. The market is currently experiencing huge investments and developments in novel equipment with high performance and output.
In May 2019, Sartorius Stedim Biotech launched a new ambr 15 cell culture microbioreactor system for improved clone selection and media and media optimization in fed-batch & perfusion mimic conditions.
Some of the key players in the global micro bioreactor market include m2p-labs GmbH, Sartorius AG, Applikon Biotechnology, Eppendorf AG, Infors AG, and many other regional and global companies.
Why Purchase the Report?
**The global micro bioreactor report will provide access to approximately 53 market data tables, 43 figures, and 180 pages.
Get your free sample proposal with a single click!